CAS No.: 1623804-44-3
Henagliflozin Catalog No. CSN20593
Synonyms: Henagliflozin;SHR3824
Henagliflozin is a sodium glucose co-tranporter 2 inhibitor, with the IC50 values against human SGLT2 and SGLT1 were 2.38 and 4324 nmol/L, respectively, and is used for treating patients with type 2diabetes mellitus.
| 规格 | 价格 | 促销价格 | 库存 | 数量 |
|---|
400-920-2911
sales@csnpharm.cn
tech@csnpharm.cn
纯度 & 质量文件
批次:
靶点选择性
生物活性
- 描述
- 临床研究
NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点 NCT02366377 Type 2 Diabetes Mellitus Phase 1 Unknown - - NCT02366351 Type 2 Diabetes Mellitus Phase 1 Unknown - China ... more >> Chinese PLA General Hospital Recruiting Beijing, China Contact: Juming Lu, PhD 010-66937166 Collapse << NCT02346175 Type 2 Diabetes Mellitus Phase 1 Completed - - - 更多
- 参考文献
- [1] Wang L, Wu C, et al. Evaluation of drug-drug interaction between henagliflozin, a novel sodium-glucose co-transporter 2 inhibitor, and metformin in healthy Chinese males. Xenobiotica. 2016 Aug;46(8):703-8.
- [2] Yong X, Wen A, et al. Pharmacokinetics and Pharmacodynamics of Henagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, in Chinese Patients with Type 2 Diabetes Mellitus. Clin Drug Investig. 2016 Mar;36(3):195-202.
实验方案
- 计算器
- 储存液制备
技术信息
| CAS号 | 1623804-44-3 | 储存条件 |
|
|
| 分子式 | C22H24ClFO7 | 运输 | 蓝冰 | |
| 分子量 | 454.87 | 别名 | Henagliflozin;SHR3824 |
